GlassScriptPhysician profile
Robin A Lacour
NPI 1548448442
$63,946.07
in general payments reported to CMS, 2019-2025
27 companies · $1,197 in 2025
The $1,197 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,533 · 2020: $28K · 2021: $23K · 2022: $2,144 · 2023: $5,033 · 2024: $2,332 · 2025: $1,197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,252 · Consulting Fee: $3,250 · Travel and Lodging: $1,482 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Education: $68.00 · Gift: $10.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,252.34 |
| Consulting Fee | $3,250.00 |
| Travel and Lodging | $1,481.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Education | $68.00 |
| Gift | $10.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $55,987.62 | 2020-2025 | Zejula, Jemperli |
| Intuitive Surgical, INC. | $4,872.16 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Olympus America INC. | $881.09 | 2023 | 4k Camera Head, Visera Elite II Video System Center |
| Tempus Ai, INC | $326.17 | 2024 | |
| Exelixis INC. | $268.04 | 2021-2022 | |
| Tg Therapeutics, INC. | $234.08 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $219.20 | 2019-2024 | Enhertu |
| Myriad Genetic Laboratories, INC. | $168.14 | 2021-2024 | Mychoice Cdx |
| Biom'Up Sa | $150.00 | 2019 | |
| Genmab U.S., INC. | $125.00 | 2023 | Tivdak |
| Coopersurgical, INC. | $120.93 | 2023 | Advincula Delineator Uterine Manipulator |
| Pacira Pharmaceuticals Incorporated | $106.85 | 2025 | Exparel |
| Merck Sharp & Dohme LLC | $82.57 | 2019-2022 | |
| Eisai INC. | $68.00 | 2025 | |
| Dendreon Pharmaceuticals LLC | $67.01 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $35.69 | 2019 | |
| Ethicon US, LLC | $30.75 | 2021 | |
| Puma Biotechnology, INC. | $29.79 | 2019 | |
| Amgen INC. | $28.94 | 2020 | |
| Clovis Oncology, INC. | $25.81 | 2019 | |
| Immunogen, INC. | $24.91 | 2023 | Elahere |
| Taiho Oncology, INC. | $18.45 | 2022 | |
| Array Biopharma INC | $17.97 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $16.88 | 2023 | Epkinly |
| Astellas Pharma US INC | $15.26 | 2020 | |
| Janssen Biotech, INC. | $13.89 | 2019 | |
| Pfizer INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Lacour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.